Related Experiment Video
Updated: Jun 13, 2025
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Inhibition of osteosarcoma metastasis in vivo by targeted downregulation of MMP1 and MMP9
Ofri Doppelt-Flikshtain1, Thabet Asbi2, Amin Younis2
1Laboratory for Bone Repair, Rambam Health Care Campus, Haifa, Israel; The Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel.
Abstract:
Osteosarcoma (OS) mortality stems from lung metastases. Matrix metalloproteinases (MMPs) facilitate metastatic dissemination by degrading extracellular matrix components. Herein we studied the impact of targeted MMP downregulation on OS metastasis. Differential gene expression analysis of human OS cell lines revealed high MMP9 expression in the majority of OS cell lines. Furthermore, 143B, a metastatic OS cell line, exhibited increased MMP1 and MMP9 mRNA levels. Gene set enrichment analysis on metastatic and non-metastatic OS patient specimens indicated epithelial-mesenchymal transition as the most enriched gene set, with MMP9 displaying strong association to genes in this network. Using the same dataset, Kaplan-Meier analysis revealed a correlation between MMP1 expression and dismal patient survival. Hence, we undertook targeted suppression of MMP1 and MMP9 gene expression in OS cell lines. The ability of OS cells to migrate and form colonies was markedly reduced upon MMP1 and MMP9 downregulation, whereas their cell proliferation capacity remained intact. MMP9 downregulation decreased tumor growth and lung metastases area in an orthotopic mouse OS model. Consistently, human OS lung metastasis specimens displayed marked MMP9 protein expression. Our findings highlight the role of MMP1 and MMP9 in OS metastasis, warranting further exploration of simultaneous inhibition of MMPs for future OS therapeutics.
Insights
Targeting matrix metalloproteinases (MMPs), specifically MMP1 and MMP9, significantly reduced osteosarcoma (OS) lung metastasis and tumor growth. This study highlights MMPs as key drivers of OS metastasis, suggesting their inhibition as a potential therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Osteosarcoma (OS) mortality is primarily driven by lung metastases.
- Matrix metalloproteinases (MMPs) are implicated in cancer metastasis by degrading the extracellular matrix.
Purpose of the Study:
- To investigate the impact of targeted downregulation of MMP1 and MMP9 on osteosarcoma metastasis.
- To explore the role of MMP1 and MMP9 in OS progression and patient survival.
Main Methods:
- Differential gene expression analysis and gene set enrichment analysis on OS cell lines and patient specimens.
- Kaplan-Meier survival analysis to correlate MMP expression with patient outcomes.
- Targeted suppression of MMP1 and MMP9 in OS cell lines and evaluation in an orthotopic mouse model.
Main Results:
- High MMP9 expression was observed in most OS cell lines, with elevated MMP1 and MMP9 in metastatic cell lines.
- MMP9 was strongly associated with epithelial-mesenchymal transition genes, a key metastatic pathway.
- Downregulation of MMP1 and MMP9 reduced OS cell migration and colony formation but not proliferation.
- MMP9 suppression decreased tumor growth and lung metastasis in vivo, with high MMP9 protein expression found in human OS lung metastases.
Conclusions:
- MMP1 and MMP9 play critical roles in osteosarcoma metastasis.
- Targeted inhibition of MMP1 and MMP9 shows therapeutic potential for reducing OS lung dissemination.
- Simultaneous inhibition of MMPs warrants further investigation as a novel therapeutic approach for osteosarcoma.
More Related Videos
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
08:47Improved Visualization of Lung Metastases at Single Cell Resolution in Mice by Combined In-situ Perfusion of Lung Tissue and X-Gal Staining of lacZ-Tagged Tumor Cells
Published on: August 21, 2012
